WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001004127) VINYLPYRROLIDINONE DERIVATIVES WITH SUBSTITUTED THIAZOLE RING
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/004127    International Application No.:    PCT/EP2000/006151
Publication Date: 18.01.2001 International Filing Date: 01.07.2000
IPC:
C07D 501/00 (2006.01)
Applicants: F. HOFFMANN-LA ROCHE AG [CH/CH]; 124 Grenzacherstrasse, CH-4070 Basle (CH) (For All Designated States Except US).
ANGEHRN, Peter [CH/CH]; (CH) (For US Only).
HEBEISEN, Paul [CH/CH]; (CH) (For US Only).
HEINZE-KRAUSS, Ingrid [DE/DE]; (DE) (For US Only).
PAGE, Malcolm [GB/CH]; (CH) (For US Only)
Inventors: ANGEHRN, Peter; (CH).
HEBEISEN, Paul; (CH).
HEINZE-KRAUSS, Ingrid; (DE).
PAGE, Malcolm; (CH)
Agent: KJELLSAA-BERGER, Hanny; 124 Grenzacherstrasse, CH-4070 Basle (CH)
Priority Data:
99113120.2 07.07.1999 EP
Title (EN) VINYLPYRROLIDINONE DERIVATIVES WITH SUBSTITUTED THIAZOLE RING
(FR) DERIVES DE VINYLPYRROLIDINONE A CYCLE THIAZOLE SUBSTITUE
Abstract: front page image
(EN)The invention is concerned with cephalosporin derivatives of general formula (I) wherein X is chlorine, bromine, fluorine, trifluoromethyl, methyl, carboxy or hydroximethyl; R1 is hydrogen or lower alkanoyl; R2 is hydrogen or an in vivo cleavable group; Y1 is a group -CHR3-; Y2 is one of the groups -CHR3-, -CHR3-CHR3- and -CHOH-CHR3-; R3 is the same or different and selected from hydrogen, hydroxy-lower alkyl and amino-lower alkyl, and readily hydrolyzable ester of compounds of formula I, as well as pharmaceutically acceptable salts of said compounds of formula I and of their esters and salts, with the manufacture of compounds aforesaid; and with their use as pharmaceutically active substances in the treatment and prophylaxis of infectious diseases.
(FR)L'invention concerne des dérivés de céphalosporine représentés par la formule générale (I), dans laquelle X représente chlore, brome, fluor, trifluorométhyle, méthyle, carboxy ou hydroxyméthyle ; R1 désigne hydrogène ou un alcanoyle inférieure ; R2 désigne hydrogène ou un groupe clivable in vivo; Y1 représente un groupe -CHR3- ; Y2 désigne l'un des groupes -CHR3-, -CHR3-CHR3- et - CHOH-CHR3- ; chaque R3 étant identique ou différent et choisi parmi hydrogène, hydroxy-alkyle inférieur et amino-alkyle inférieur. L'invention concerne également un ester rapidement hydrolysable de ces composés de formule I, des sels pharmaceutiquement acceptables desdits composés de formule I et des esters et des sels de ceux-ci. L'invention concerne, en outre, la fabrication des composés susmentionnés, et leur utilisation comme substances pharmaceutiquement actives dans le traitement et la prophylaxie de maladies infectieuses.
Designated States: AE, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)